Bluestone Center for Oral Health Research
About Bluestone Center Research Expertise Research Services Patient Resources Study Participation Oral Health Registry Contact
  Sitemap


Project Management Team

Dr. Frederick A. Curro, DMD, PhD
Director of Pharmacotherapeutic/Regulatory Research

Dr. Curro is the Director of Pharmacotherapeutic/Regulatory Research at the Bluestone Center for Oral Health Research. He is a clinical pharmacologist/regulatory and medical affairs specialist with over 30 years experience in the pharmaceutical/biotechnology sector. Dr. Curro served most recently as Vice President/Director of Corporate Clinical and Medical Affairs at GlaxoSmithKline and at Block Drug Company, Inc., and as Executive Director of Clinical Research and Operations for Transkaryotic Therapies, Inc., a Cambridge, Massachusetts-based proteomic/genetic biotechnology company. His unique background in medicine, chronic pain and pharmacology brings to the Bluestone Center a rich and broad expertise in the field of Pharmacotherapeutic Research. He has conducted all phases of clinical trials from I-IV. Dr. Curro is a member of the United States Pharmacopeia Expert Advisory Committee on Dermatology and Special Populations/Clinical Pharmacology for 2005-2010.


Top of Page | Previous Page

Dr. Frederick A. Curro